Acute kidney injury

10 trials 2 recruiting MedDRA PT
10 Registered trials
2 Recruiting
7 Unique sponsors
10 Unique IMPs
4 Commercial trials
Drug classes (ATC)
— ATC code not specified 6
C Cardiology (ATC C) 2
A Gastroenterology (ATC A) 1
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 8 substances
ARB 1 substance
SGLT2 inhibitor 1 substance
Phase III: 4 Phase II: 4 Phase III/IV: 1 Phase IV: 1

Filter these 10 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 10 trials

Phase III

4 trials
  • Assistance Publique Hopitaux De Paris Academic
    IMP not specified
    2023-508664-30-00 1 country n=306
    Pending
  • Assistance Publique Hopitaux De Paris Academic
    IRBESARTAN
    2024-515845-40-00 1 country 2022 n=508
    Ended
  • Hospital Clinico Universitario De Valencia Academic
    EMPAGLIFLOZIN
    2024-519997-37-00 1 country n=608
    Pending
  • Region Oestergoetland Academic
    IMP not specified
    2024-513575-40-01 1 country n=380
    Pending

Phase II

4 trials

Phase III/IV

1 trial
  • Universitaet Muenster Academic
    ANGIOTENSIN II
    2024-517771-21-00 1 country 2025 n=1,022
    Recruiting

Phase IV

1 trial
  • Universitaet Muenster Academic
    MAGNESIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE, MALIC ACID, SODIUM ACETATE TRIHYDRATE; MAGNESIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE, SODIUM ACETATE TRIHYDRATE; POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE; SODIUM CHLORIDE, CALCIUM ACETATE, MAGNESIUM ACETATE TETRAHYDRATE, POTASSIUM ACETATE, SODIUM ACETATE TRIHYDRATE
    2025-523914-10-00 1 country 2026 n=660
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Novartis Pharma AG Commercial 2 Phase II 0
Universitaet Muenster Academic 2 Phase III/IV, Phase IV 2
Assistance Publique Hopitaux De Paris Academic 2 Phase III 0
Genentech Inc. Commercial 1 Phase II 0
M2rlab S.L. Commercial 1 Phase II 0
Hospital Clinico Universitario De Valencia Academic 1 Phase III 0
Region Oestergoetland Academic 1 Phase III 0
New trials by year
2022
1
2023
1
2024
1
2025
2
2026
2
← All indication landscapes